Shen C - Search Results

1

Role of chemoradiotherapy in intermediate prognosis nasopharyngeal carcinoma.

Xu T, Hu C, Wang X, Shen C. Xu T, et al. Among authors: shen c. Oral Oncol. 2011 May;47(5):408-13. doi: 10.1016/j.oraloncology.2011.03.008. Epub 2011 Apr 2. Oral Oncol. 2011. PMID: 21459659 Clinical Trial.

2

[Analysis of 68 patients with pituitary adenoma treated by radiotherapy].

Hu CS, Ying HM, Shen CY. Hu CS, et al. Ai Zheng. 2002 Oct;21(10):1154-7. Ai Zheng. 2002. PMID: 12508665 Chinese.

3

Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.

Shen C, Lu JJ, Gu Y, Zhu G, Hu C, He S. Shen C, et al. Laryngoscope. 2008 Jul;118(7):1206-10. doi: 10.1097/MLG.0b013e31816ed587. Laryngoscope. 2008. PMID: 18418278 Clinical Trial.

4

Squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: the impact of radiotherapy.

Lu X, Hu C, Ji Q, Shen C, Feng Y. Lu X, et al. Among authors: shen c. Tumori. 2009 Mar-Apr;95(2):185-90. doi: 10.1177/030089160909500209. Tumori. 2009. PMID: 19579864

5

Carcinoma of the nasopharynx in young patients: a single institution experience.

Shen C, Gao Y, Xu T, Wang X, Ying H, Hu C. Shen C, et al. Clin Oncol (R Coll Radiol). 2009 Oct;21(8):617-22. doi: 10.1016/j.clon.2009.07.005. Epub 2009 Aug 5. Clin Oncol (R Coll Radiol). 2009. PMID: 19660923

6

Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck.

Shen C, Xu T, Huang C, Hu C, He S. Shen C, et al. Oral Oncol. 2012 May;48(5):445-9. doi: 10.1016/j.oraloncology.2011.12.002. Epub 2011 Dec 29. Oral Oncol. 2012. PMID: 22209446

7

Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.

Ou X, Shen C, Kong L, Wang X, Ding J, Gao Y, Xu T, Hu C. Ou X, et al. Among authors: shen c. Oral Oncol. 2012 Oct;48(10):1045-1050. doi: 10.1016/j.oraloncology.2012.04.011. Epub 2012 May 24. Oral Oncol. 2012. PMID: 22633108

8

Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.

Shi Q, Shen C, Kong L, Wang X, Ding J, Gao Y, Xu T, Hu C. Shi Q, et al. Among authors: shen c. Radiat Oncol. 2014 Jan 6;9:7. doi: 10.1186/1748-717X-9-7. Radiat Oncol. 2014. PMID: 24393418 Free PMC article.

9

Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.

Zhou X, Ou X, Xu T, Wang X, Shen C, Ding J, Hu C. Zhou X, et al. Among authors: shen c. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):261-9. doi: 10.1016/j.ijrobp.2014.05.036. Epub 2014 Jul 24. Int J Radiat Oncol Biol Phys. 2014. PMID: 25066214

10

Cetuximab in combination with chemoradiotherapy in the treatment of recurrent and/or metastatic nasopharyngeal carcinoma.

Xu T, Ou X, Shen C, Hu C. Xu T, et al. Among authors: shen c. Anticancer Drugs. 2016 Jan;27(1):66-70. doi: 10.1097/CAD.0000000000000294. Anticancer Drugs. 2016. PMID: 26352217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,191 results

Search Page

Filters